-- Avita Medical（ASX:AVH）は、多施設共同臨床試験「Cohealyx-I」の中間結果において、全層皮膚創傷患者における皮膚移植までの平均期間が、実臨床におけるベンチマーク値33.2日と比較して約20日短縮され、13.6日となったことを、水曜日にオーストラリア証券取引所に提出した書類で明らかにした。
提出書類によると、本試験の主要評価項目は自家移植（植皮）までの期間であり、副次評価項目には創傷治癒および安全性に関する結果が含まれる。
同社によると、40名の患者を対象とした中間解析では、移植までの期間の中央値は11日であり、最短で5日で移植が達成され、患者の25%が7日以内に、72%が14日以内に移植を受けた。
本試験は現在も継続中で、全データセットは今年中に得られる見込みである。
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:VTR reported Q1 revenue of $1.66B, up 22.0% Y/Y (+5.8% Q/Q) and $81M ahead of consensus estimates, with same-store cash NOI rising 8.7% Y/Y driven by strong Senior Housing Operating (SHO) performance (+15.4% Y/Y). Outpatient Medical and Research (OMR) contributed +2.4% NOI growth while Triple-Net (NNN) added +1.6% Y/Y growth, demonstrating diversified portfolio strength across all business segments. SHOP fundamentals remain exceptionally robust with occupancy increasing 310 bps Y/Y (+30 bps Q/Q) to 90.4% and average monthly revenue per occupied room (RevPOR) up 5.0% Y/Y to $5,512, demonstrating continued strong pricing power in senior housing markets. Cash NOI margins expanded significantly with SHOP margins increasing 170 bps to 30.0%, while OMR margins contracted 80 bps to 64.6% compared to Q1 2025 levels. The strong operational execution in SHOP continues to drive both occupancy gains and margin expansion, positioning VTR well for sustained NOI growth going forward.
Tower (ASX:TWR, NZE:TWR) said AM Best has reaffirmed its financial strength rating at "A-Excellent" and its long-term issuer credit rating at "a-Excellent," both with a stable outlook, according to a Tuesday filing with the New Zealand bourse.The agency attributed the ratings to the company's strong balance sheet, adequate operating performance, neutral business profile, and sound risk management, the filing added.
US natural gas futures climbed in after-hours trading on Monday as a cooler weather outlook and easing supply conditions triggered some short covering.The front-month Henry Hub contract and the continuous contract both rose 0.75% to $2.542 per million British thermal units.Prices briefly touched an intraday high of around $2.63/MMBtu in earlier trade."Nat-gas prices settled higher on Monday as short covering emerged amid colder US weather forecasts, potentially boosting nat-gas heating demand," Barchart said.Weather-driven demand shifts were a key driver. NatGasWeather.com said models have moved cooler versus last week, adding more heating demand days while reducing cooling demand. The forecaster said the change leaves the outlook less bearish and closer to neutral or slightly bullish.On the demand side, residential and commercial consumption increased sharply to 15.2 billion cubic feet per day from 12.5 Bcf/d as cooler temperatures boosted heating needs. Power burn remained steady at 32.5 Bcf/d and is projected to average 30.3 Bcf/d for the week, up from 29 Bcf/d last week, Gelber & Associates said.Total US natural gas production was flat last week, averaging around 106.5 Bcf/d, NRG Energy said. Trading Economics said output fell by around 4.1 Bcf/d over the past 18 days to an 11-week low of 108.1 Bcf/d, as major producers such as EQT scaled back output in response to low prices.Both NRG Energy and Gelber said Canadian imports fell to 4.7-4.8 Bcf/d from 5.5 Bcf/d.On the export side, Barchart, citing BNEF data, said LNG flows were 19.5 Bcf/d, down 2.1% from last week's robust levels. Trading Economics put the April average feedgas flow at 18.9 Bcf/d so far and noted it was near record highs."Today saw cooler forecast revisions, softer production, and steady LNG demand, which offers limited support for prices. That said, overall fundamental balances are not tight enough to fully change the story," Gelber said Monday.